These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22320002)

  • 1. Australian and New Zealand governments agree to proceed with the joint regulatory agency for therapeutic products.
    Moore J
    J Law Med; 2011 Dec; 19(2):272-4. PubMed ID: 22320002
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the Therapeutic Goods Administration and the Medicine and Medical Devices Safety Authority in evaluating complementary and alternative medicines in Australia and New Zealand.
    Ghosh D; Skinner M; Ferguson LR
    Toxicology; 2006 Apr; 221(1):88-94. PubMed ID: 16481089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosimilars approval process.
    Zuñiga L; Calvo B
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):374-7. PubMed ID: 19925842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switzerland: one year's experience with new regulations and a new agency.
    Voelksen R
    Med Device Technol; 2003 Mar; 14(2):28-9. PubMed ID: 12698697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent legal developments and the authority of the Australian Therapeutic Goods Administration.
    Shirlow E; Faunce T
    J Law Med; 2009 May; 16(5):764-9. PubMed ID: 19554858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of regulating stem cell-based products.
    von Tigerstrom BJ
    Trends Biotechnol; 2008 Dec; 26(12):653-8. PubMed ID: 18977047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed changes to New Zealand's medicines legislation in the Medicines Amendment Bill 2011.
    Moore J
    J Bioeth Inq; 2013 Mar; 10(1):59-66. PubMed ID: 23283819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
    Smirniotopoulos A
    Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulators need to regulate. For health and safety issues, the nation needs watchdogs to be on guard.
    May D
    Mod Healthc; 2010 Mar; 40(9):16. PubMed ID: 20344831
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and U.S. Regulatory considerations in the nonclinical use of medical ultrasound devices.
    Phillips RA; Stratmeyer ME; Harris GR
    Ultrasound Med Biol; 2010 Aug; 36(8):1224-8. PubMed ID: 20447750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal overprotection.
    Friedman JH
    Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378
    [No Abstract]   [Full Text] [Related]  

  • 13. European drug regulation--anti-protectionism or consumer protection?
    Lancet; 1991 Jun; 337(8757):1571-2. PubMed ID: 1675711
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract]   [Full Text] [Related]  

  • 15. American roulette--contaminated dietary supplements.
    Cohen PA
    N Engl J Med; 2009 Oct; 361(16):1523-5. PubMed ID: 19812394
    [No Abstract]   [Full Text] [Related]  

  • 16. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 17. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 18. Consumer protection from an EU regulation on the mandatory labelling of genetically modified food.
    Clin Lab; 2004; 50(5-6):380-1. PubMed ID: 15209444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contaminated dietary supplements.
    Carvajal R
    N Engl J Med; 2010 Jan; 362(3):274; author reply 274. PubMed ID: 20089984
    [No Abstract]   [Full Text] [Related]  

  • 20. [How can customized modifications of medical products for research purposes be legally manufactured in compliance with the Medical Products Regulation?].
    Haindl H
    Biomed Tech (Berl); 1997; 42 Suppl():358. PubMed ID: 9517190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.